61-2-10. Certification for use of topical ocular pharmaceutical agents; display. (Repealed effective July 1, 2016.)
A. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists licensed on the effective date of this section who have completed appropriate forms issued by the board and submitted proof of successful completion of the educational requirements for certification established by the board, which requirements shall be not less than those required in Paragraph (2) of Subsection B of this section.
B. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists licensed after the effective date of this section who have completed appropriate forms issued by the board and submitted proof of:
(1) having satisfactorily completed a course in pharmacology as applied to optometry with particular emphasis on the topical application of diagnostic pharmaceutical agents to the eye for the purpose of examination of the human eye and the analysis of ocular functions, which course is offered by an institution accredited by a regional or professional accreditation organization recognized or approved by the national commission on accrediting or the United States secretary of education; or
(2) having postgraduate education with a minimum of seventy hours of instruction in general and ocular pharmacology as applied to optometry taught by an accredited institution and approved by the board.
C. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists who have successfully completed an examination and submitted proof of having satisfactorily completed a course in pharmacology as applied to optometry, with particular emphasis on the application of pharmaceutical agents for the purpose of examination of the human eye, analysis of ocular functions and treatment of visual defects or abnormal conditions of the human eye and its adnexa. The course shall constitute a minimum of one hundred classroom-clinical hours of instruction in general and ocular pharmacology, including therapeutic pharmacology, as applied to optometry, and shall be taught by an accredited institution and approved by the board.
D. The certification authorized by this section shall be displayed in a conspicuous place in the optometrist's principal office or place of business.
61-2-10. Certification for use of topical ocular pharmaceutical agents; display. (Repealed effective July 1, 2016.)
A. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists licensed on the effective date of this section who have completed appropriate forms issued by the board and submitted proof of successful completion of the educational requirements for certification established by the board, which requirements shall be not less than those required in Paragraph (2) of Subsection B of this section.
B. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists licensed after the effective date of this section who have completed appropriate forms issued by the board and submitted proof of:
(1) having satisfactorily completed a course in pharmacology as applied to optometry with particular emphasis on the topical application of diagnostic pharmaceutical agents to the eye for the purpose of examination of the human eye and the analysis of ocular functions, which course is offered by an institution accredited by a regional or professional accreditation organization recognized or approved by the national commission on accrediting or the United States secretary of education; or
(2) having postgraduate education with a minimum of seventy hours of instruction in general and ocular pharmacology as applied to optometry taught by an accredited institution and approved by the board.
C. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists who have successfully completed an examination and submitted proof of having satisfactorily completed a course in pharmacology as applied to optometry, with particular emphasis on the application of pharmaceutical agents for the purpose of examination of the human eye, analysis of ocular functions and treatment of visual defects or abnormal conditions of the human eye and its adnexa. The course shall constitute a minimum of one hundred classroom-clinical hours of instruction in general and ocular pharmacology, including therapeutic pharmacology, as applied to optometry, and shall be taught by an accredited institution and approved by the board.
D. The certification authorized by this section shall be displayed in a conspicuous place in the optometrist's principal office or place of business.
61-2-10. Certification for use of topical ocular pharmaceutical agents; display. (Repealed effective July 1, 2016.)
A. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists licensed on the effective date of this section who have completed appropriate forms issued by the board and submitted proof of successful completion of the educational requirements for certification established by the board, which requirements shall be not less than those required in Paragraph (2) of Subsection B of this section.
B. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists licensed after the effective date of this section who have completed appropriate forms issued by the board and submitted proof of:
(1) having satisfactorily completed a course in pharmacology as applied to optometry with particular emphasis on the topical application of diagnostic pharmaceutical agents to the eye for the purpose of examination of the human eye and the analysis of ocular functions, which course is offered by an institution accredited by a regional or professional accreditation organization recognized or approved by the national commission on accrediting or the United States secretary of education; or
(2) having postgraduate education with a minimum of seventy hours of instruction in general and ocular pharmacology as applied to optometry taught by an accredited institution and approved by the board.
C. The board shall issue certification for the use of topical ocular pharmaceutical agents to optometrists who have successfully completed an examination and submitted proof of having satisfactorily completed a course in pharmacology as applied to optometry, with particular emphasis on the application of pharmaceutical agents for the purpose of examination of the human eye, analysis of ocular functions and treatment of visual defects or abnormal conditions of the human eye and its adnexa. The course shall constitute a minimum of one hundred classroom-clinical hours of instruction in general and ocular pharmacology, including therapeutic pharmacology, as applied to optometry, and shall be taught by an accredited institution and approved by the board.
D. The certification authorized by this section shall be displayed in a conspicuous place in the optometrist's principal office or place of business.
